LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 28, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 69.60%77M | -20.46%58.7M | 1,237.50%10.7M | 311.63%243.8M | 579.84%123.8M | 869.49%45.4M | 311.46%73.8M | 101.65%800K | -187.80%-115.2M | -172.47%-25.8M |
Net income from continuing operations | 42.58%50.9M | 18.02%45.2M | 25.83%49.2M | 630.81%144.7M | 227.42%31.6M | 185.60%35.7M | 100.52%38.3M | 200.77%39.1M | -66.44%19.8M | -663.64%-24.8M |
Operating gains losses | 16.00%2.9M | 22.73%2.7M | 20.00%4.2M | -71.94%22M | -79.82%13.8M | -32.43%2.5M | -53.19%2.2M | 118.75%3.5M | 1,033.33%78.4M | 827.66%68.4M |
Depreciation and amortization | 19.29%23.5M | 46.25%23.4M | 96.26%21M | 36.21%63.2M | 76.84%16.8M | 74.34%19.7M | 37.93%16M | -23.57%10.7M | 9.69%46.4M | -8.65%9.5M |
Deferred tax | 142.15%5.1M | -4.35%-7.2M | 2.86%-3.4M | -17.76%-25.2M | 40.00%-2.7M | -53.16%-12.1M | 48.12%-6.9M | -181.40%-3.5M | -1,428.57%-21.4M | -36.36%-4.5M |
Other non cash items | 46.67%-800K | -33.33%-2M | 6.67%-1.4M | 96.24%-5.2M | 99.50%-700K | -600.00%-1.5M | -600.00%-1.5M | -400.00%-1.5M | -3,837.84%-138.3M | -23,333.33%-139.4M |
Change In working capital | -273.91%-8.6M | -131.98%-7.1M | -41.28%-66.4M | 127.08%34.5M | 27.27%61.6M | 93.48%-2.3M | 137.12%22.2M | 41.76%-47M | -2,648.00%-127.4M | 2,004.35%48.4M |
-Change in receivables | 33.33%-14.4M | -101.50%-300K | -95.36%-29.5M | 10,300.00%30.6M | 129.61%47.3M | -35.85%-21.6M | 229.87%20M | -245.19%-15.1M | 98.48%-300K | 121.75%20.6M |
-Change in inventory | -162.96%-3.4M | 122.41%1.3M | 43.40%-12M | 94.19%-3.1M | -26.00%18.5M | 116.12%5.4M | 69.95%-5.8M | 17.19%-21.2M | -154.29%-53.4M | 4,066.67%25M |
-Change in payables and accrued expense | -33.81%9.2M | -201.25%-8.1M | -132.71%-24.9M | 109.50%7M | -250.00%-4.2M | -1.42%13.9M | 131.87%8M | 83.66%-10.7M | -260.92%-73.7M | -97.10%2.8M |
Cash from discontinued investing activities | 17.42%-25.6M | 33.33%-1.2M | 96.15%-200K | -63.43%-35.3M | 640.00%2.7M | -282.72%-31M | 59.09%-1.8M | 39.53%-5.2M | -149.77%-21.6M | 96.62%-500K |
Operating cash flow | 256.94%51.4M | -20.14%57.5M | 338.64%10.5M | 252.41%208.5M | 580.99%126.5M | 202.86%14.4M | 283.21%72M | 92.31%-4.4M | -178.35%-136.8M | -226.44%-26.3M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 9.38%-5.8M | 105.88%32.4M | -7,692.31%-303.9M | -992.34%-570.2M | -32.35%-9M | -1,700.00%-6.4M | -28,894.74%-550.9M | 91.12%-3.9M | 82.94%-52.2M | 96.36%-6.8M |
Capital expenditure reported | -1.28%-7.9M | -121.28%-10.4M | -147.50%-9.9M | -50.31%-23.9M | -25.42%-7.4M | -95.00%-7.8M | -20.51%-4.7M | -90.48%-4M | -65.63%-15.9M | -180.95%-5.9M |
Net business purchase and sale | 1,150.00%2.1M | --0 | ---294.1M | -1,267.50%-547M | --300K | -114.29%-200K | -136,875.00%-547.1M | --0 | 84.92%-40M | --0 |
Net other investing changes | --0 | 4,655.56%42.8M | 0.00%100K | -81.08%700K | -111.11%-1.9M | -46.67%1.6M | --900K | --100K | 111.86%3.7M | 97.72%-900K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 9.38%-5.8M | 105.88%32.4M | -7,692.31%-303.9M | -762.63%-570.2M | -32.35%-9M | -1,700.00%-6.4M | -28,894.74%-550.9M | 93.25%-3.9M | -121.04%-66.1M | 96.31%-6.8M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -4,772.73%-53.6M | -117.12%-62.2M | 365.34%292.7M | 875.94%309.6M | -8,984.62%-115.5M | -120.00%-1.1M | 1,117.65%363.3M | 671.82%62.9M | 76.22%-39.9M | 200.00%1.3M |
Net issuance payments of debt | 148.78%40.8M | -104.65%-18.3M | 411.49%342.7M | 94,740.00%474.2M | -287.50%-3.1M | 110.26%16.4M | 12,409.38%393.9M | 2,130.30%67M | -98.82%500K | 52.94%-800K |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---33.7M | --0 |
Net other financing activities | -439.43%-94.4M | -43.46%-43.9M | -1,119.51%-50M | -2,356.72%-164.6M | -5,452.38%-112.4M | -660.87%-17.5M | -2,650.00%-30.6M | 46.75%-4.1M | 96.81%-6.7M | 425.00%2.1M |
Cash from discontinued financing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 400.00%1M | 0 |
Financing cash flow | -4,772.73%-53.6M | -117.12%-62.2M | 365.34%292.7M | 895.89%309.6M | -8,984.62%-115.5M | -117.74%-1.1M | 1,138.00%363.3M | 651.75%62.9M | 76.79%-38.9M | 262.50%1.3M |
Net cash flow | ||||||||||
Beginning cash position | 39.12%133M | -50.40%105.5M | -33.23%104.9M | -60.33%157.1M | -45.54%102M | -51.02%95.6M | -21.08%212.7M | -60.33%157.1M | 479.80%396M | -66.56%187.3M |
Current changes in cash | -215.94%-8M | 123.96%27.7M | -101.28%-700K | 78.45%-52.1M | 106.29%2M | 193.24%6.9M | -51.71%-115.6M | 143.20%54.6M | -175.30%-241.8M | 80.67%-31.8M |
Effect of exchange rate changes | 980.00%4.4M | 86.67%-200K | 30.00%1.3M | -103.45%-100K | -43.75%900K | 0.00%-500K | -178.95%-1.5M | 1,100.00%1M | -56.06%2.9M | 300.00%1.6M |
End cash Position | 26.86%129.4M | 39.12%133M | -50.40%105.5M | -33.23%104.9M | -33.23%104.9M | -45.54%102M | -51.02%95.6M | -21.08%212.7M | -60.33%157.1M | -60.33%157.1M |
Free cash flow | 559.09%43.5M | -30.01%47.1M | 107.14%600K | 220.89%184.6M | 469.88%119.1M | 136.67%6.6M | 255.79%67.3M | 85.83%-8.4M | -192.55%-152.7M | -272.19%-32.2M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |